Skip to main content
Contemporary Clinical Trials Communications logoLink to Contemporary Clinical Trials Communications
. 2019 Sep 12;16:100450. doi: 10.1016/j.conctc.2019.100450

Corrigendum to “The significant cost of systematic reviews and meta-analyses: A call for greater involvement of machine learning to assess the promise of clinical trials” [Contemp. Clin. Trials Commun. 16 (2019) 100443]

Matthew Michelson a,, Katja Reuter b,c
PMCID: PMC6915791  PMID: 31872151

The initially published search results did not match the most current results from PubMed, as perhaps the search algorithms changed from initial research to publication. Therefore, in the interest of transparency, we have updated the article accordingly.

Please see the revised sections – The Result section of the abstract, the correct values in Table 1, and the updated Results section. All of which are provided below.

Results: The formula estimated that each SLR costs approximately $141,194.80. We found that on average, the ten largest pharmaceutical companies write 41.71 and the ten major academic institutions publish 177.32 SLRs per year. On average, the total cost of all SLRs per year to each academic institution amounts to $25,036,661.94 and for each pharmaceutical company is $5,889,235.11.

Table 1.

The number of comparative studies performed by the top 10 NIH-funded research institutions and the top 10 largest pharmaceutical companies by revenue. Example of PubMed query: (meta analysis OR systematic review OR "comparative effectiveness”) AND (“Roche”[ad]) AND (“2013/01/01"[PDat]: "2018/12/31"[PDat]).

Average NIH-funded research institution Number of articles in the last 5 years Company Number of articles in the last 5 years
Johns Hopkins University 1238 J&J (Janssen) 152
University of Michigan 1163 Roche 80
University of Pittsburgh 927 Pfizer 223
Washington University in St. Louis 198 Novartis 186
Stanford University 1082 Sanofi 98
University of California, San Francisco 330 GSK 170
University of Pennsylvania 1152 Merck 120
Massachusetts General Hospital 1163 AbbVie 41
Brigham and Women's Hospital 1338 Bayer 38
University of California San Diego 275 Abbot 60
5 year average 886.60 116.80
1 year average 177.32 23.36

Results

We found that on average, each major academic institution will publish 177.32 and each pharmaceutical company will publish 23.36 SLRs per year (Table 1). According to our formula, each single SLR costs $141,194.80 ($82,090 X 1.72). Given that 44% of meta-analyses in the pharmaceutical industry go unpublished (i.e., Pr(unbpub) is 0.44), we estimate the pharmaceutical industry publishes 41.71 studies, on average, per year. Therefore, the total cost of all SLRs per year for each pharmaceutical company averages $5,889,235.11, and each academic institution averages $25,036,661.94 ($141,194.80 X 177.32), as we assume all studies are published in academia (i.e., Pr(unpub) is 0)).


Articles from Contemporary Clinical Trials Communications are provided here courtesy of Elsevier

RESOURCES